We are live on
!
Find out more
ORPH
Orphazyme A/S
ORPH
ORPH
Delisted
ORPH was delisted on the 30th of March, 2022.
22 hedge funds and large institutions have $4.47M invested in Orphazyme A/S in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
10% more funds holding
Funds holding: 20 → 22 (+2)
5% more call options, than puts
Call options by funds: $1.78M | Put options by funds: $1.7M
22% less capital invested
Capital invested by funds: $5.77M → $4.47M (-$1.3M)
Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
4
Closed
7
Calls
$1.78M
Puts
$1.7M
Net Calls
+$80K
Net Calls Change
+$1.22M
Top Buyers
Top Sellers
| 1 |
Jane Street
New York
|
-$1.05M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$552K |
| 3 |
CG
Cutler Group
San Francisco,
California
|
-$160K |
| 4 |
Morgan Stanley
New York
|
-$83.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$63.6K |
